BTD+AA with Quarterly Release this week? They don't seem to be casting their net wide for funds ie. just enough to survive a month or two each time, probably from the same set of investors who've drunk the science Kool-Aid like many of us. By now, they should be close to receiving a yes or no on BTD. If the FTD designation has been used effectively, the FDA should already know everything they need to know, given the pre-BTD Q&A that happened recently with senior FDA folks. Let's hope they get it in time for the quarterly release. If on the other hand, the FDA asks for more data, we might be dealing with a new FDA team by mid next year.